Please join us in welcoming Dr. Sudhir Borgonha to the FARF team as Translational Science Director. In this role, Sudhir will lead development of FA translational science by working with academic and industry partners to pursue clinical research opportunities to better understand and treat FA. He will manage translational projects including the development of a clinical registry and tissue bank. Sudhir is a physician researcher with over 15 years of experience leading early stage projects and companies. Most recently, as the Medical Director at Strand Genomics, he was instrumental in developing customized gene panels in rare diseases and cancer, including launching a liquid biopsy test. He oversaw clinical reporting in collaboration with clinicians across the globe for over 5,000 patients per year, of which over a 1,000 were in rare diseases. He is a graduate of St. John’s Medical College, Bangalore and the Sloan School of Management, MIT. Sudhir is passionate about integrating emerging technologies into medicine. He is an aspiring writer and still has mixed feelings about why Bob Dylan won the Nobel prize in literature and Philip Roth didn’t.
News
Dr. Sudhir Borgonha Joins FARF as Translational Science Director
Jun 13th, 2018
Categories: Announcements
Related News
Oct 4th, 2024
The 36th Annual Fanconi Anemia (FA) Scientific Symposium and Adult Retreat took place in Charlotte, North Carolina in September 2024, and brought together researchers, clinicians, advocates, individuals with FA and community members from across the globe. This year’s theme, “It Takes...
Announcements
Jul 15th, 2024
The Fanconi Cancer Foundation (FCF) is excited to announce that Dr. Isis Sroka has been named CEO effective August 1, 2024. She succeeds Mark Quinlan who served as Executive Director since 2017 and recently announced his departure. Quinlan will continue in an advisory role with FCF through a transition period.
Announcements
Apr 29th, 2024
That's why we're thrilled to announce the launch of the Fanconi Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research, a flagship funding opportunity in partnership with the American Association for Cancer Research (AACR).
Announcements